Global IVD Market Research Bundle: World Market for In Vitro Diagnostics, United States In Vitro Diagnostics Markets, Companion Diagnostic Testing Markets & Next Generation Sequencing Markets

Monday, April 10, 2017 1:42 PM UTC

Dublin, April 10, 2017 -- Research and Markets has announced the addition of the "2017 IVD Market Research Bundle (The Worldwide Market for In Vitro Diagnostic Tests, NGS, Companion, US IVD)" report to their offering.

The IVD market is estimated to be nearly 61 billion dollars.

There are a number of drivers of the market that should be watched in 2017. The IVD industry has been the beneficiary of genomic research and unfortunately the march of obesity, diabetes, cancer, cardiac disease and infectious diseases, worldwide.These situations have created demand for highly specific, sensitive and sometimes expensive tests.

This bundle of previously published studies allows decision-makers and researchers to review critical information in order to be prepared for events coming in 2017.

These topics fit together well as the IVD industry integrates next-generation sequencing into clinical diagnostics, reaches for companion opportunities and specifically targets the world's largest healthcare market. The bundle contains the full reports as they were published.

Studies Included:

The World Market for In Vitro Diagnostics, 10th Edition - Published August 2016
United States In Vitro Diagnostics Markets - Published July 2016
Companion Diagnostic Testing Markets - Published April 2016
Next Generation Sequencing Markets - Published September 2016

Companies Mentioned

AB SCIEX Pte Ltd
Abbott Diagnostics
Affymetrix Inc
Agilent Technologies
Alere Inc
Animas Corporation
Angle plc
ApoCell, Inc
Arkray
Ascensia Diabetes Care (formerly Bayer Diabetes Care)
Beckman Coulter, Inc.
Becton, Dickinson and Company (BD)
Bigfoot Biomedical
Biocept, Inc
Biodesix, Inc
bioMérieux Inc
Bio-Rad Laboratories, Inc
Bruker BioSciences Corporation
CellaVision AB
Debiotech SA
DexCom, Inc
Diagnostica Stago, S.A.S
Eiken Chemical Co., Ltd
EliTech Group S.A.S
Epic Sciences Inc
ERBA Mannheim
Fujirebio Diagnostics, Inc
Gentag, Inc
Glytec Inc
Haemokinesis Pty Ltd
Hologic, Inc
iHealth Lab Inc
Immucor, Inc
LabCorp, Laboratory Corporation of America
Lifescan Inc
Luminex Corporation
Mindray Medical International Limited
Myriad Genetics
Oncascan Limited
PerkinElmer, Inc. (PE)
QIAGEN N.V
Quest Diagnostics
Roche Diagnostics
Savanna (formerly Wildcat)
Siemens Healthcare Diagnostics
Solana Molecular System
Tandem Diabetes Care, Inc
Verily (formerly Google Life Sciences)
West Medica

For more information about this report visit http://www.researchandmarkets.com/research/z33vbm/2017_ivd_market



CONTACT: Research and Markets
         Laura Wood, Senior Manager
         [email protected]
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716
         Related Topics: Diagnostics, In Vitro Diagnostics, Molecular Diagnostics

Editor's Picks

Breathing through your nose when you exercise may make your runs easier

Entrepreneurs are facing a mental health crisis — here's how to help them

Are fish oil supplements as healthy as we think? And is eating fish better?

Will AI kill our creativity? It could – if we don’t start to value and protect the traits that make us human

Does AI have a right to free speech? Only if it supports our right to free thought

How can I lower my cholesterol? Do supplements work? How about psyllium or probiotics?

Why we need to set limits on sperm donation

Aging with a healthy brain: How lifestyle changes could help prevent up to 40% of dementia cases

Seven techniques to avoid weight regain, approved by experts

Global IVD Market Research Bundle: World Market for In Vitro Diagnostics, United States In Vitro Diagnostics Markets, Companion Diagnostic Testing Markets & Next Generation Sequencing Markets

Editor's Picks

Welcome to EconoTimes